Europe Liver Disease Diagnostics Market By End User (Hospitals, Laboratories and Other End Users), By Diagnosis Technique (Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques), By Country, Industry Analysis and Forecast, 2020 - 2026
The Europe Liver Disease Diagnostics Market would witness market growth of 6.1% CAGR during the forecast period (2020-2026).
Growing incidences of obesity, metabolic syndrome, diabetes, and cardiovascular diseases that contribute to liver disease are another significant factor that fuels the growth of the liver disease treatment market. In addition, an increase in the incidence of liver disease due to the side effects of other medications such as acetaminophen and poor hygienic and sanitation conditions is projected to drive the demand in the coming years.
Liver disease in the United Kingdom has increased dramatically, particularly in people under 65 years of age — a marked contrast to all other major causes of death that have decreased in younger age groups. The epidemic was caused by alcohol, obesity and hepatitis C. LFTs are usually abnormal due to a number of causes, such as drinking too much, fatty liver due to obesity, infections, rare liver diseases, and certain cancers — but they may be a symptom of potentially fatal liver disease.
The liver is the body's factory, producing vital proteins and breaking down or excreting waste products. Liver disease is usually a silent illness in its early stages. Liver function tests (LFTs) are commonly available blood tests associated with liver damage, so early detection of liver diseases would be possible. Millions of these tests are carried out every year in the United Kingdom by doctors and nurses for a variety of symptoms and conditions ranging from tiredness, yellowing of the skin (in white people) to the whiteness of the eyes due to jaundice.
Based on End User, the market is segmented into Hospitals, Laboratories and Other End Users. Based on Diagnosis Technique, the market is segmented into Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Siemens AG (Siemens Healthineers), Bayer AG, Merck & Co., Inc., Sanofi S.A., Novartis AG, Pfizer, Inc., and Randox laboratories limited
Scope of the Study
Market Segmentation:
By End User
Growing incidences of obesity, metabolic syndrome, diabetes, and cardiovascular diseases that contribute to liver disease are another significant factor that fuels the growth of the liver disease treatment market. In addition, an increase in the incidence of liver disease due to the side effects of other medications such as acetaminophen and poor hygienic and sanitation conditions is projected to drive the demand in the coming years.
Liver disease in the United Kingdom has increased dramatically, particularly in people under 65 years of age — a marked contrast to all other major causes of death that have decreased in younger age groups. The epidemic was caused by alcohol, obesity and hepatitis C. LFTs are usually abnormal due to a number of causes, such as drinking too much, fatty liver due to obesity, infections, rare liver diseases, and certain cancers — but they may be a symptom of potentially fatal liver disease.
The liver is the body's factory, producing vital proteins and breaking down or excreting waste products. Liver disease is usually a silent illness in its early stages. Liver function tests (LFTs) are commonly available blood tests associated with liver damage, so early detection of liver diseases would be possible. Millions of these tests are carried out every year in the United Kingdom by doctors and nurses for a variety of symptoms and conditions ranging from tiredness, yellowing of the skin (in white people) to the whiteness of the eyes due to jaundice.
Based on End User, the market is segmented into Hospitals, Laboratories and Other End Users. Based on Diagnosis Technique, the market is segmented into Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Siemens AG (Siemens Healthineers), Bayer AG, Merck & Co., Inc., Sanofi S.A., Novartis AG, Pfizer, Inc., and Randox laboratories limited
Scope of the Study
Market Segmentation:
By End User
- Hospitals, Laboratories and Other End Users
- Imaging
- Biopsy
- Endoscopy
- Laboratory tests and
- Other Diagnosis Techniques
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Boston Scientific Corporation
- Siemens AG (Siemens Healthineers)
- Bayer AG
- Merck & Co., Inc.
- Sanofi S.A.
- Novartis AG
- Pfizer, Inc.
- Randox laboratories limited
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Liver Disease Diagnostics Market, by End User
1.4.2 Europe Liver Disease Diagnostics Market, by Diagnosis Technique
1.4.3 Europe Liver Disease Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER
3.1 Europe Hospitals Market by Country
3.2 Europe Laboratories Market by Country
3.3 Europe Other End Users Market by Country
CHAPTER 4. EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE
4.1 Europe Imaging Market by Country
4.2 Europe Biopsy Market by Country
4.3 Europe Endoscopy Market by Country
4.4 Europe Laboratory tests Market by Country
4.5 Europe Other Diagnosis Techniques Market by Country
CHAPTER 5. EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY
5.1 Germany Liver Disease Diagnostics Market
5.1.1 Germany Liver Disease Diagnostics Market by End User
5.1.2 Germany Liver Disease Diagnostics Market by Diagnosis Technique
5.2 UK Liver Disease Diagnostics Market
5.2.1 UK Liver Disease Diagnostics Market by End User
5.2.2 UK Liver Disease Diagnostics Market by Diagnosis Technique
5.3 France Liver Disease Diagnostics Market
5.3.1 France Liver Disease Diagnostics Market by End User
5.3.2 France Liver Disease Diagnostics Market by Diagnosis Technique
5.4 Russia Liver Disease Diagnostics Market
5.4.1 Russia Liver Disease Diagnostics Market by End User
5.4.2 Russia Liver Disease Diagnostics Market by Diagnosis Technique
5.5 Spain Liver Disease Diagnostics Market
5.5.1 Spain Liver Disease Diagnostics Market by End User
5.5.2 Spain Liver Disease Diagnostics Market by Diagnosis Technique
5.6 Italy Liver Disease Diagnostics Market
5.6.1 Italy Liver Disease Diagnostics Market by End User
5.6.2 Italy Liver Disease Diagnostics Market by Diagnosis Technique
5.7 Rest of Europe Liver Disease Diagnostics Market
5.7.1 Rest of Europe Liver Disease Diagnostics Market by End User
5.7.2 Rest of Europe Liver Disease Diagnostics Market by Diagnosis Technique
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.1.5.3 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Siemens AG (Siemens Healthineers)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Product Launches and Product Expansions:
6.5 Bayer AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Merck & Co., Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Sanofi S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Pfizer, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Randox Laboratories Limited
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Liver Disease Diagnostics Market, by End User
1.4.2 Europe Liver Disease Diagnostics Market, by Diagnosis Technique
1.4.3 Europe Liver Disease Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER
3.1 Europe Hospitals Market by Country
3.2 Europe Laboratories Market by Country
3.3 Europe Other End Users Market by Country
CHAPTER 4. EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE
4.1 Europe Imaging Market by Country
4.2 Europe Biopsy Market by Country
4.3 Europe Endoscopy Market by Country
4.4 Europe Laboratory tests Market by Country
4.5 Europe Other Diagnosis Techniques Market by Country
CHAPTER 5. EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY
5.1 Germany Liver Disease Diagnostics Market
5.1.1 Germany Liver Disease Diagnostics Market by End User
5.1.2 Germany Liver Disease Diagnostics Market by Diagnosis Technique
5.2 UK Liver Disease Diagnostics Market
5.2.1 UK Liver Disease Diagnostics Market by End User
5.2.2 UK Liver Disease Diagnostics Market by Diagnosis Technique
5.3 France Liver Disease Diagnostics Market
5.3.1 France Liver Disease Diagnostics Market by End User
5.3.2 France Liver Disease Diagnostics Market by Diagnosis Technique
5.4 Russia Liver Disease Diagnostics Market
5.4.1 Russia Liver Disease Diagnostics Market by End User
5.4.2 Russia Liver Disease Diagnostics Market by Diagnosis Technique
5.5 Spain Liver Disease Diagnostics Market
5.5.1 Spain Liver Disease Diagnostics Market by End User
5.5.2 Spain Liver Disease Diagnostics Market by Diagnosis Technique
5.6 Italy Liver Disease Diagnostics Market
5.6.1 Italy Liver Disease Diagnostics Market by End User
5.6.2 Italy Liver Disease Diagnostics Market by Diagnosis Technique
5.7 Rest of Europe Liver Disease Diagnostics Market
5.7.1 Rest of Europe Liver Disease Diagnostics Market by End User
5.7.2 Rest of Europe Liver Disease Diagnostics Market by Diagnosis Technique
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.1.5.3 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Siemens AG (Siemens Healthineers)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Product Launches and Product Expansions:
6.5 Bayer AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Merck & Co., Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Sanofi S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Pfizer, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Randox Laboratories Limited
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 4 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 5 EUROPE HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 12 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 13 EUROPE IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 GERMANY LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 26 GERMANY LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 27 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 28 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 29 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 30 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 31 UK LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 32 UK LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 33 UK LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 34 UK LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 35 UK LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 36 UK LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 37 FRANCE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 38 FRANCE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 39 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 40 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 41 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 42 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 43 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 44 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 45 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 46 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 47 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 48 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 49 SPAIN LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 50 SPAIN LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 51 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 52 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 53 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 54 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 55 ITALY LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 56 ITALY LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 57 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 58 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 59 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 60 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 61 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 62 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 63 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 64 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 65 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 66 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 67 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 68 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 69 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 70 KEY INFORMATION – SIEMENS AG
TABLE 71 KEY INFORMATION – BAYER AG
TABLE 72 KEY INFORMATION - MERCK & CO., INC.
TABLE 73 KEY INFORMATION – SANOFI S.A.
TABLE 74 KEY INFORMATION – NOVARTIS AG
TABLE 75 KEY INFORMATION – PFIZER, INC.
TABLE 76 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 1 EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 4 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 5 EUROPE HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 12 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 13 EUROPE IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 GERMANY LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 26 GERMANY LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 27 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 28 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 29 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 30 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 31 UK LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 32 UK LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 33 UK LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 34 UK LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 35 UK LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 36 UK LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 37 FRANCE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 38 FRANCE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 39 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 40 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 41 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 42 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 43 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 44 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 45 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 46 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 47 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 48 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 49 SPAIN LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 50 SPAIN LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 51 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 52 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 53 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 54 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 55 ITALY LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 56 ITALY LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 57 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 58 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 59 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 60 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 61 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 62 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 63 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 64 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 65 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 66 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 67 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 68 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 69 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 70 KEY INFORMATION – SIEMENS AG
TABLE 71 KEY INFORMATION – BAYER AG
TABLE 72 KEY INFORMATION - MERCK & CO., INC.
TABLE 73 KEY INFORMATION – SANOFI S.A.
TABLE 74 KEY INFORMATION – NOVARTIS AG
TABLE 75 KEY INFORMATION – PFIZER, INC.
TABLE 76 KEY INFORMATION – RANDOX LABORATORIES LIMITED
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 RECENT STRATEGIES AND DEVELOPMENTS: SIEMENS AG
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 RECENT STRATEGIES AND DEVELOPMENTS: SIEMENS AG
